User menu

Renal transplantation in autosomal dominant polycystic kidney disease

Bibliographic reference Kanaan, Nada ; Devuyst, Olivier ; Pirson, Yves. Renal transplantation in autosomal dominant polycystic kidney disease. In: Nature Reviews Nephrology, Vol. 10, no.8, p. 455-465 (2014)
Permanent URL http://hdl.handle.net/2078.1/146853
  1. Torres Vicente E, Harris Peter C, Pirson Yves, Autosomal dominant polycystic kidney disease, 10.1016/s0140-6736(07)60601-1
  2. Harris Peter C., Torres Vicente E., Polycystic Kidney Disease, 10.1146/annurev.med.60.101707.125712
  3. Ong Albert C.M., Harris Peter C., Molecular pathogenesis of ADPKD: The polycystin complex gets complex, 10.1111/j.1523-1755.2005.00201.x
  4. Garcia Iglesias Carmen, Torres Vicente E., Offord Kenneth P., Holley Keith E., Beard C. Mary, Kurland Leonard T., Epidemiology of Adult Polycystic Kidney Disease, Olmsted County, Minnesota: 1935–1980, 10.1016/s0272-6386(83)80044-4
  5. Davies F., Q. J. Med., 79, 477 (1991)
  6. Collins Allan J., Kasiske Bertram, Herzog Charles, Chavers Blanche, Foley Robert, Gilbertson David, Grimm Richard, Liu Jiannong, Louis Thomas, Manning Willard, Matas Arthur, McBean Marshall, Murray Anne, St. Peter Wendy, Xue Jay, Fan Qiao, Guo Haifeng, Li Shuling, Li Suying, Roberts Tricia, Snyder Jon, Solid Craig, Wang Changchun, Weinhandl Eric, Arko Cheryl, Chen Shu-Cheng, Dalleska Frederick, Daniels Frank, Dunning Stephan, Ebben James, Frazier Eric, Johnson Roger, Sheets Daniel, Forrest Beth, Berrini Delaney, Constantini Edward, Everson Susan, Frederick Pamela, Eggers Paul, Agodoa Lawrence, Excerpts from the United States Renal Data System 2004 Annual Data Report: Atlas of end-stage renal disease in the United States, 10.1053/j.ajkd.2004.10.009
  7. Pirson Yves, Extrarenal Manifestations of Autosomal Dominant Polycystic Kidney Disease, 10.1053/j.ackd.2010.01.003
  8. Luciano R. L., Dahl N. K., Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management, 10.1093/ndt/gft437
  9. Torra R., Sarquella J., Calabia J., Marti J., Ars E., Fernandez-Llama P., Ballarin J., Prevalence of Cysts in Seminal Tract and Abnormal Semen Parameters in Patients with Autosomal Dominant Polycystic Kidney Disease, 10.2215/cjn.05311107
  10. Kumar S., Adeva M., King B. F., Kamath P. S., Torres V. E., Duodenal diverticulosis in autosomal dominant polycystic kidney disease, 10.1093/ndt/gfl405
  11. Driscoll James A., Bhalla Sanjeev, Liapis Helen, Ibricevic Aida, Brody Steven L., Autosomal Dominant Polycystic Kidney Disease Is Associated With an Increased Prevalence of Radiographic Bronchiectasis, 10.1378/chest.07-2147
  12. Harris P. C., Bae K. T., Rossetti S., Torres V. E., Grantham J. J., Chapman A. B., Guay-Woodford L. M., King B. F., Wetzel L. H., Baumgarten D. A., Kenney P. J., Consugar M., Klahr S., Bennett W. M., Meyers C. M., Zhang Q., Thompson P. A., Zhu F., Miller J. P., , Cyst Number but Not the Rate of Cystic Growth Is Associated with the Mutated Gene in Autosomal Dominant Polycystic Kidney Disease, 10.1681/asn.2006080835
  13. Dobin A., Kimberling W. J., Pettinger W., Bailey-Wilson J. E., Shugart Y. Y., Gabow P., Segregation analysis of autosomal dominant polycystic kidney disease : Segregation Analysis of ADPKD, 10.1002/gepi.1370100305
  14. , Polycystic kidney disease: The complete structure of the PKD1 gene and its protein, 10.1016/0092-8674(95)90339-9
  15. Hughes Jim, Ward Christopher J., Peral Belén, Aspinwall Richard, Clark Kevin, San Millán José L., Gamble Vicki, Harris Peter C., The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains, 10.1038/ng0695-151
  16. Mochizuki T., Wu G., Hayashi T., Xenophontos S. L., Veldhuisen B., Saris J. J., Reynolds D. M., Cai Y., Gabow P. A., Pierides A., Kimberling W. J., Breuning M. H., Deltas C. C., Peters D. J. M., Somlo S., PKD2, a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein, 10.1126/science.272.5266.1339
  17. Yoder B. K., Role of Primary Cilia in the Pathogenesis of Polycystic Kidney Disease, 10.1681/asn.2006111215
  18. Hateboer Nick, v Dijk Marjan A, Bogdanova Nadja, Coto Eliecer, Saggar-Malik Anand K, Millan Jose L San, Torra Roser, Breuning Martijn, Ravine David, Comparison of phenotypes of polycystic kidney disease types 1 and 2, 10.1016/s0140-6736(98)03495-3
  19. Cornec-Le Gall E., Audrezet M.-P., Chen J.-M., Hourmant M., Morin M.-P., Perrichot R., Charasse C., Whebe B., Renaudineau E., Jousset P., Guillodo M.-P., Grall-Jezequel A., Saliou P., Ferec C., Le Meur Y., Type of PKD1 Mutation Influences Renal Outcome in ADPKD, 10.1681/asn.2012070650
  20. Paterson A. D., Progressive Loss of Renal Function Is an Age-Dependent Heritable Trait in Type 1 Autosomal Dominant Polycystic Kidney Disease, 10.1681/asn.2004090758
  21. Fain Pamela R., McFann Kimberly K., Taylor Matthew R.G., Tison Maryellyn, Johnson Ann M., Reed Berenice, Schrier Robert W., Modifier genes play a significant role in the phenotypic expression of PKD111See Editorial by Pei, p. 1630., 10.1111/j.1523-1755.2005.00203.x
  22. Magistroni R., Genotype-Renal Function Correlation in Type 2 Autosomal Dominant Polycystic Kidney Disease, 10.1097/01.asn.0000061774.90975.25
  23. Persu Alexandre, Duyme Michel, Pirson Yves, Lens Xosé M., Messiaen Thierry, Breuning Martijn H., Chauveau Dominique, Levy Micheline, Grünfeld Jean-Pierre, Devuyst Olivier, Comparison between siblings and twins supports a role for modifier genes in ADPKD, 10.1111/j.1523-1755.2004.66003.x
  24. Alam Ahsan, Perrone Ronald D., Management of ESRD in Patients With Autosomal Dominant Polycystic Kidney Disease, 10.1053/j.ackd.2009.12.006
  25. Haynes Richard, Kheradmand Farhad, Winearls Christopher G., Survival after Starting Renal Replacement Treatment in Patients with Autosomal Dominant Polycystic Kidney Disease: A Single-Centre 40-Year Study, 10.1159/000334429
  26. Mosconi G., Persici E., Cuna V., Pedone M., Tonioli M., Conte D., Ricci A., Feliciangeli G., La Manna G., Nanni Costa A., Stefoni S., Renal Transplant in Patients with Polycystic Disease: The Italian Experience, 10.1016/j.transproceed.2013.07.016
  27. Jacquet Antoine, Pallet Nicolas, Kessler Michèle, Hourmant Maryvonne, Garrigue Valérie, Rostaing Lionel, Kreis Henri, Legendre Christophe, Mamzer-Bruneel Marie-France, Outcomes of renal transplantation in patients with autosomal dominant polycystic kidney disease: a nationwide longitudinal study : Renal transplantation and autosomal dominant polycystic kidney disease, 10.1111/j.1432-2277.2011.01237.x
  28. Orskov B., Romming Sorensen V., Feldt-Rasmussen B., Strandgaard S., Improved Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease in Denmark, 10.2215/cjn.01460210
  29. Perrone Ronald D., Ruthazer Robin, Terrin Norma C., Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: Contribution of extrarenal complications to mortality, 10.1053/ajkd.2001.27720
  30. Kirkman Matthew A., van Dellen David, Mehra Sanjay, Campbell Babatunde A., Tavakoli Afshin, Pararajasingam Ravi, Parrott Neil R., Riad Hany N., McWilliam Lorna, Augustine Titus, Native nephrectomy for autosomal dominant polycystic kidney disease: before or after kidney transplantation? : OPTIMAL TIMING FOR NEPHRECTOMY IN ADPKD, 10.1111/j.1464-410x.2010.09938.x
  31. Bennett W. M., Peritransplant management of retained native kidneys in autosomal dominant polycystic kidney disease, 10.1093/ndt/gfs176
  32. Kasiske B. L., J. Am. Soc. Nephrol., 6, 1 (1995)
  33. , Abramowicz D., Cochat P., Claas F., Dudley C., Harden P., Heeman U., Hourmant M., Maggiore U., Pascual J., Salvadori M., Spasovski G., Squifflet J.-P., Steiger J., Torres A., Vanholder R., Van Biesen W., Viklicky O., Zeier M., Nagler E., Guideline, 10.1093/ndt/gft218
  34. Yarimizu Shiroh N., Susan Luay P., Straffon Ralph A., Stewart Bruce H., Magnusson Magnus O., Nakamoto Saturu S., Mortality and morbidity in pretransplant bilateral nephrectomy Analysis of 305 cases, 10.1016/0090-4295(78)90367-9
  35. Mendelssohn D. C., Clin. Nephrol., 30, 315 (1988)
  36. Patel P, Horsfield C, Compton F, Taylor J, Koffman G, Olsburgh J, Native nephrectomy in transplant patients with autosomal dominant polycystic kidney disease, 10.1308/003588411x582690
  37. Neeff H. P., Pisarski P., Tittelbach-Helmrich D., Karajanev K., Neumann H. P. H., Hopt U. T., Drognitz O., One hundred consecutive kidney transplantations with simultaneous ipsilateral nephrectomy in patients with autosomal dominant polycystic kidney disease, 10.1093/ndt/gfs118
  38. Cornelis F., Couzi L., Le Bras Y., Hubrecht R., Dodré E., Geneviève M., Pérot V., Wallerand H., Ferrière J. M., Merville P., Grenier N., Embolization of Polycystic Kidneys as an Alternative to Nephrectomy Before Renal Transplantation: A Pilot Study : Kidney Embolization in PKRD Before Graft, 10.1111/j.1600-6143.2010.03251.x
  39. Wagner Matthew D., Prather Jonathan C., Barry John M., Selective, Concurrent Bilateral Nephrectomies at Renal Transplantation for Autosomal Dominant Polycystic Kidney Disease, 10.1016/j.juro.2007.01.146
  40. Kramer Andrew, Sausville Justin, Haririan Abdolreza, Bartlett Stephen, Cooper Matthew, Phelan Michael, Simultaneous Bilateral Native Nephrectomy and Living Donor Renal Transplantation are Successful for Polycystic Kidney Disease: The University of Maryland Experience, 10.1016/j.juro.2008.10.008
  41. Martin Aaron D., Mekeel Kristin L., Castle Erik P., Vaish Sneha S., Martin George L., Moss Adyr A., Mulligan David C., Heilman Raymond L., Reddy Kunam S., Andrews Paul E., Laparoscopic bilateral native nephrectomies with simultaneous kidney transplantation : LAPAROSCOPIC BILATERAL NATIVE NEPHRECTOMIES WITH SIMULTANEOUS KIDNEY TRANSPLANTATION, 10.1111/j.1464-410x.2012.11379.x
  42. Verhoest Grégory, Delreux Arnaud, Mathieu Romain, Patard Jean-Jacques, Vigneau Cécile, Rioux-Leclercq Nathalie, Bensalah Karim, Transperitoneal Laparoscopic Nephrectomy for Autosomal Dominant Polycystic Kidney Disease, 10.4293/108680812x13462882736178
  43. Gevers Tom J. G., Drenth Joost P. H., Diagnosis and management of polycystic liver disease, 10.1038/nrgastro.2012.254
  44. Strazzabosco Mario, Somlo Stefan, Polycystic Liver Diseases: Congenital Disorders of Cholangiocyte Signaling, 10.1053/j.gastro.2011.04.030
  45. Bae K. T., Magnetic Resonance Imaging Evaluation of Hepatic Cysts in Early Autosomal-Dominant Polycystic Kidney Disease: The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease Cohort, 10.2215/cjn.00080605
  46. Alvaro Domenico, Barbaro Barbara, Franchitto Antonio, Onori Paolo, Glaser Shannon S., Alpini Gianfranco, Francis Heather, Marucci Luca, Sterpetti Paola, Ginanni-Corradini Stefano, Onetti Muda Andrea, Dostal David E., De Santis Adriano, Attili Adolfo F., Benedetti Antonio, Gaudio Eugenio, Estrogens and Insulin-Like Growth Factor 1 Modulate Neoplastic Cell Growth in Human Cholangiocarcinoma, 10.2353/ajpath.2006.050464
  47. Chapman Arlene B., Cystic Disease in Women: Clinical Characteristics and Medical Management, 10.1053/jarr.2003.50005
  48. Sherstha R., Hepatology, 26, 1282 (1997)
  49. Caroli A., Antiga L., Cafaro M., Fasolini G., Remuzzi A., Remuzzi G., Ruggenenti P., Reducing Polycystic Liver Volume in ADPKD: Effects of Somatostatin Analogue Octreotide, 10.2215/cjn.05380709
  50. Hogan M. C., Masyuk T. V., Page L. J., Kubly V. J., Bergstralh E. J., Li X., Kim B., King B. F., Glockner J., Holmes D. R., Rossetti S., Harris P. C., LaRusso N. F., Torres V. E., Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease, 10.1681/asn.2009121291
  51. van Keimpema Loes, Nevens Frederik, Vanslembrouck Ragna, van Oijen Martijn G.H., Hoffmann Aswin L., Dekker Helena M., de Man Robert A., Drenth Joost P.H., Lanreotide Reduces the Volume of Polycystic Liver: A Randomized, Double-Blind, Placebo-Controlled Trial, 10.1053/j.gastro.2009.07.052
  52. Grunfeld J. P., Adv. Nephrol. Necker Hosp., 14, 1 (1985)
  53. Jouret F., Lhommel R., Beguin C., Devuyst O., Pirson Y., Hassoun Z., Kanaan N., Positron-Emission Computed Tomography in Cyst Infection Diagnosis in Patients with Autosomal Dominant Polycystic Kidney Disease, 10.2215/cjn.06900810
  54. Fishbane Steven, Safety in iron management, 10.1016/s0272-6386(03)00373-1
  55. Jouret F., Lhommel R., Devuyst O., Annet L., Pirson Y., Hassoun Z., Kanaan N., Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities, 10.1093/ndt/gfs352
  56. Sallee M., Rafat C., Zahar J.-R., Paulmier B., Grunfeld J.-P., Knebelmann B., Fakhouri F., Cyst Infections in Patients with Autosomal Dominant Polycystic Kidney Disease, 10.2215/cjn.01870309
  57. TELENTI AMALIO, TORRES VICENTE E., GROSS JOHN B., VAN SCOY ROBERT E., BROWN MANUEL L., HATTERY ROBERT R., Hepatic Cyst Infection in Autosomal Dominant Polycystic Kidney Disease, 10.1016/s0025-6196(12)65154-4
  58. Chauveau D., J. Am. Soc. Nephrol., 11, 1767 (2000)
  59. Kanaan Nada, Goffin Eric, Pirson Yves, Devuyst Olivier, Hassoun Ziad, Carbohydrate Antigen 19-9 as a Diagnostic Marker for Hepatic Cyst Infection in Autosomal Dominant Polycystic Kidney Disease, 10.1053/j.ajkd.2009.12.023
  60. Waanders Esmé, van Keimpema Loes, Brouwer Johannes T., van Oijen Martijn G. H., Aerts Raymond, Sweep Fred C. G. J., Nevens Frederik, Drenth Joost P. H., Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease, 10.1111/j.1478-3231.2009.02055.x
  61. Van Keimpema Loes, De Koning Daan B., Van Hoek Bart, Van Den Berg Aad P., Van Oijen Martijn G. H., De Man Robert A., Nevens Frederik, Drenth Joost P. H., Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases : Clinical characterization of PCLD, 10.1111/j.1478-3231.2010.02247.x
  62. Torres Vicente E., Harris Peter C., Autosomal dominant polycystic kidney disease: the last 3 years, 10.1038/ki.2009.128
  63. Hoevenaren Inge A., Wester Ruth, Schrier Robert W., McFann Kim, Doctor R. Brian, Drenth Joost P. H., Everson Gregory T., Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease : Clinical forms of polycystic liver, 10.1111/j.1478-3231.2007.01595.x
  64. van Keimpema L., Höckerstedt K., Treatment of polycystic liver disease : Leading article, 10.1002/bjs.6738
  65. Ruggenenti Piero, Remuzzi Andrea, Ondei Patrizia, Fasolini Giorgio, Antiga Luca, Ene-Iordache Bogdan, Remuzzi Giuseppe, Epstein Franklin H., Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease, 10.1111/j.1523-1755.2005.00395.x
  66. Hogan M. C., Masyuk T. V., Page L., Holmes D. R., Li X., Bergstralh E. J., Irazabal M. V., Kim B., King B. F., Glockner J. F., LaRusso N. F., Torres V. E., Somatostatin analog therapy for severe polycystic liver disease: results after 2 years, 10.1093/ndt/gfs152
  67. Russell Robert T, Surgical management of polycystic liver disease, 10.3748/wjg.v13.i38.5052
  68. Schnelldorfer Thomas, Torres Vicente E., Zakaria Shaheen, Rosen Charles B., Nagorney David M., Polycystic Liver Disease : A Critical Appraisal of Hepatic Resection, Cyst Fenestration, and Liver Transplantation, 10.1097/sla.0b013e3181ad83dc
  69. Nadim M. K., Davis C. L., Sung R., Kellum J. A., Genyk Y. S., Simultaneous Liver-Kidney Transplantation: A Survey of US Transplant Centers : SLK Practice in US Transplant Centers, 10.1111/j.1600-6143.2012.04176.x
  70. Davis Connie L., Impact of pretransplant renal failure: When is listing for kidney-liver indicated?, 10.1002/lt.20617
  71. Drenth Joost P.H., Chrispijn Melissa, Nagorney David M., Kamath Patrick S., Torres Vicente E., Medical and surgical treatment options for polycystic liver disease1, 10.1002/hep.24036
  72. Fong Tse-Ling, Bunnapradist Suphamai, Jordan Stanley C., Selby R. Rick, Cho Yong W., Analysis of the United Network for Organ Sharing database comparing renal allografts and patient survival in combined liver-kidney transplantation with the contralateral allografts in kidney alone or kidney-pancreas transplantation1 : , 10.1097/01.tp.0000071204.03720.bb
  73. Kirchner Gabriele I., Rifai Kinan, Cantz Tobias, Nashan Bjoern, Terkamp Christoph, Becker Thomas, Strassburg Christian, Barg-Hock Hannelore, Wagner Siegfried, Lück Rainer, Klempnauer Juergen, Manns Michael P., Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation, 10.1002/lt.20780
  74. Torra Roser, Badenas Cèlia, Darnell Alejandro, Brú Concepció, Escorsell Angels, Estivill Xavier, Autosomal dominant polycystic kidney disease with anticipation and Caroli's disease associated with a PKD1 mutation Rapid Communication, 10.1038/ki.1997.300
  75. Shedda Susan, Robertson Amanda, CAROLI?S SYNDROME AND ADULT POLYCYSTIC KIDNEY DISEASE, 10.1111/j.1445-2197.2006.03659.x
  76. Jordon Deanna, Harpaz Noam, Thung Swan N., Caroli's disease and adult polycystic kidney disease: a rarely recognized association, 10.1111/j.1600-0676.1989.tb00375.x
  77. Aguilar Martin, Meterissian Sarkis, Levesque Sebastien, Andonian Sero, Nephrectomy in patients with Caroli’s and ADPKD may be associated with increased morbidity, 10.5489/cuaj.10054
  78. Habib Shahid, Shakil Obaid, Couto Osvaldo F., Demetris Anthony J., Fung John J., Marcos Amadeo, Chopra Kapil, Caroli's disease and orthotopic liver transplantation, 10.1002/lt.20719
  79. Yamamoto Takayuki, Watarai Yoshihiko, Kobayashi Takaaki, Matsuda Yoshiko, Tsujita Makoto, Hiramitsu Takahisa, Nanmoku Koji, Goto Norihiko, Katayama Akio, Tominaga Yoshihiro, Uchida Kazuharu, Kidney Volume Changes in Patients With Autosomal Dominant Polycystic Kidney Disease After Renal Transplantation : , 10.1097/tp.0b013e318246f910
  80. Temmerman F., Gevers T., Ho T. A., Vanslembrouck R., Coudyzer W., van Pelt J., Bammens B., Pirson Y., Drenth J. P., Nevens F., Safety and efficacy of different lanreotide doses in the treatment of polycystic liver disease: pooled analysis of individual patient data, 10.1111/apt.12384
  81. Pirson Y., J. Am. Soc. Nephrol., 13, 269 (2002)
  82. Irazabal M. V., Huston J., Kubly V., Rossetti S., Sundsbak J. L., Hogan M. C., Harris P. C., Brown R. D., Torres V. E., Extended Follow-Up of Unruptured Intracranial Aneurysms Detected by Presymptomatic Screening in Patients with Autosomal Dominant Polycystic Kidney Disease, 10.2215/cjn.09731110
  83. Chauveau Dominique, Pirson Yves, Verellen-Dumoulin Christine, Macnicol Anne, Gonzalo Ana, Grünfeld Jean-Pierre, Intracranial aneurysms in autosomal dominant polycystic kidney disease, 10.1038/ki.1994.151
  84. Rinkel G.J.E., Natural history, epidemiology and screening of unruptured intracranial aneurysms, 10.1016/j.neurad.2007.11.004
  85. Broderick J. P., Brown R. D., Sauerbeck L., Hornung R., Huston J., Woo D., Anderson C., Rouleau G., Kleindorfer D., Flaherty M. L., Meissner I., Foroud T., Charles E., Moomaw J., Connolly E. S., , Greater Rupture Risk for Familial as Compared to Sporadic Unruptured Intracranial Aneurysms, 10.1161/strokeaha.108.542571
  86. Wiebers David O, Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment, 10.1016/s0140-6736(03)13860-3
  87. Ishibashi T., Murayama Y., Urashima M., Saguchi T., Ebara M., Arakawa H., Irie K., Takao H., Abe T., Unruptured Intracranial Aneurysms: Incidence of Rupture and Risk Factors, 10.1161/strokeaha.108.521674
  88. Vlak Monique HM, Algra Ale, Brandenburg Raya, Rinkel Gabriël JE, Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis, 10.1016/s1474-4422(11)70109-0
  89. Li Lucia M., Bulters Diederik O., Kirollos Ramez W., A mathematical model of utility for single screening of asymptomatic unruptured intracranial aneurysms at the age of 50 years, 10.1007/s00701-012-1371-8
  90. Schrier R. W., Repeat Imaging for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease with Initially Negative Studies: A Prospective Ten-Year Follow-up, 10.1097/01.asn.0000118527.74850.66
  91. Belz Mark M., Fick-Brosnahan Godela M., Hughes Richard L., Rubinstein David, Chapman Arlene B., Johnson Ann M., Mcfann Kim K., Kaehny William D., Gabow Patricia A., Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney disease, 10.1046/j.1523-1755.2003.00918.x
  92. Gibbs Gordon F., Huston John, Qian Qi, Kubly Vickie, Harris Peter C., Brown Robert D., Torres Vicente E., Follow-up of intracranial aneurysms in autosomal-dominant polycystic kidney disease, 10.1111/j.1523-1755.2004.00572.x
  93. Oliveras Anna, Roquer Jaume, Puig Josep M, Rodriguez Ana, Mir Marisa, Orfila M Antonia, Masramon Jordi, Lloveras Josep, Stroke in renal transplant recipients: epidemiology, predictive risk factors and outcome, 10.1034/j.1399-0012.2003.02042.x
  94. Abedini Sadollah, Holme Ingar, Fellström Bengt, Jardine Alan, Cole Edward, Maes Bart, Holdaas Hallvard, Cerebrovascular Events in Renal Transplant Recipients : , 10.1097/tp.0b013e31818bfce8
  95. Hadimeri H., Norden G., Friman S., Nyberg G., Autosomal dominant polycystic kidney disease in a kidney transplant population, 10.1093/ndt/12.7.1431
  96. Fick G. M., J. Am. Soc. Nephrol., 5, 2048 (1995)
  97. Yoo David J, Agodoa Lawrence, Yuan Christina M, Abbott Kevin C, Nee Robert, Risk of intracranial hemorrhage associated with autosomal dominant polycystic kidney disease in patients with end stage renal disease, 10.1186/1471-2369-15-39
  98. Ravine D., Sheffield Lj, Danks D.M., Gibson R.N., Walker R.G., Kincaid-Smith P., Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1, 10.1016/s0140-6736(94)92026-5
  99. Pei Y., Obaji J., Dupuis A., Paterson A. D., Magistroni R., Dicks E., Parfrey P., Cramer B., Coto E., Torra R., San Millan J. L., Gibson R., Breuning M., Peters D., Ravine D., Unified Criteria for Ultrasonographic Diagnosis of ADPKD, 10.1681/asn.2008050507
  100. Peral B., Am. J. Hum. Genet., 54, 899 (1994)
  101. Zhao X., Paterson A. D., Zahirieh A., He N., Wang K., Pei Y., Molecular Diagnostics in Autosomal Dominant Polycystic Kidney Disease: Utility and Limitations, 10.2215/cjn.03430807
  102. Rossetti S., Consugar M. B., Chapman A. B., Torres V. E., Guay-Woodford L. M., Grantham J. J., Bennett W. M., Meyers C. M., Walker D. L., Bae K., Zhang Q., Thompson P. A., Miller J. P., Harris P. C., , Comprehensive Molecular Diagnostics in Autosomal Dominant Polycystic Kidney Disease, 10.1681/asn.2006121387
  103. Garcia-Gonzalez Miguel A., Jones Jeffrey G., Allen Susan K., Palatucci Christopher M., Batish Sat D., Seltzer William K., Lan Zheng, Allen Erica, Qian Feng, Lens Xose M., Pei York, Germino Gregory G., Watnick Terry J., Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease, 10.1016/j.ymgme.2007.05.004
  104. Harris Peter C., Rossetti Sandro, Molecular diagnostics for autosomal dominant polycystic kidney disease, 10.1038/nrneph.2010.18
  105. Audrézet Marie-Pierre, Cornec-Le Gall Emilie, Chen Jian-Min, Redon Sylvia, Quéré Isabelle, Creff Joelle, Bénech Caroline, Maestri Sandrine, Le Meur Yann, Férec Claude, Autosomal dominant polycystic kidney disease: Comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients, 10.1002/humu.22103
  106. Barua M., Cil O., Paterson A. D., Wang K., He N., Dicks E., Parfrey P., Pei Y., Family History of Renal Disease Severity Predicts the Mutated Gene in ADPKD, 10.1681/asn.2009020162
  107. Fitzpatrick Peter M., Torres Vicente E., Charboneau J. William, Offord Kenneth P., Holley Keith E., Zincke Horst, Long-Term Outcome of Renal Transplantation in Autosomal Dominant Polycystic Kidney Disease, 10.1016/s0272-6386(12)80523-3
  108. FLORUN KLAAS W., CHANG PETER C., VAN DER WOUDE FOKKO J., VAN BOCKEL J. HAJO, VAN SAASE JAN L.C.M., LONG-TERM CARDIOVASCULAR MORBIDITY AND MORTALITY IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE PATIENTS AFTER RENAL TRANSPLANTATION : , 10.1097/00007890-199401000-00014
  109. Cameron J. S., Valderrabano F., Foreword, 10.1093/ndt/10.supp2.1
  110. Pirson Y., Christophe J. L., Goffin E., Outcome of renal replacement therapy in autosomal dominant polycystic kidney disease, 10.1093/ndt/11.supp6.24
  111. THAYSEN JØRN HESS, THOMSEN HENRIK S., SASS ANTON, KRISTENSEN JØRGEN KVIST, Volume Changes in Polycystic Kidneys during Chronic Dialysis and after Renal Transplantation, 10.1111/j.0954-6820.1985.tb01656.x
  112. Ishikawa Isao, Tateishi Keita, Kitada Hirohisa, Shinoda Akira, Regression of Adult Type Polycystic Kidneys during Chronic Intermittent Hemodialysis. Is It a Universal Phenomenon?, 10.1159/000183138
  113. Ho Thien Anh, Godefroid Nathalie, Gruzon Damien, Haymann Jean-Philippe, Maréchal Céline, Wang Xueqi, Serra Andreas, Pirson Yves, Devuyst Olivier, Autosomal dominant polycystic kidney disease is associated with central and nephrogenic defects in osmoregulation, 10.1038/ki.2012.225
  114. Ecder T., J. Am. Soc. Nephrol., 12, 194 (2001)
  115. Ecder Tevfik, Schrier Robert W., Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease, 10.1038/nrneph.2009.13
  116. Hossack Kenneth F., Leddy Cheryl L., Johnson Ann M., Schrier Robert W., Gabow Patricia A., Echocardiographic Findings in Autosomal Dominant Polycystic Kidney Disease, 10.1056/nejm198810063191404
  117. Lumiaho Anne, Ikäheimo Risto, Miettinen Raija, Niemitukia Lea, Laitinen Tomi, Rantala Arto, Lampainen Erkki, Laakso Markku, Hartikainen Juha, Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1, 10.1053/ajkd.2001.29216
  118. Qian Q., Hartman R. P., King B. F., Torres V. E., Increased Occurrence of Pericardial Effusion in Patients with Autosomal Dominant Polycystic Kidney Disease, 10.2215/cjn.01920507
  119. Ducloux D, Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus, 10.1093/ndt/14.5.1244
  120. De Mattos Angelo M., Olyaei Ali J., Prather Jonathan C., Golconda Muralikrishna S., Barry John M., Norman Douglas J., Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation, 10.1111/j.1523-1755.2005.67132.x
  121. Hamer Rizwan A., Chow Chern L., Ong Albert C. M., McKane William S., Polycystic Kidney Disease Is a Risk Factor for New-Onset Diabetes After Transplantation : , 10.1097/01.tp.0000248759.37146.3d
  122. Pietrzak-Nowacka Maria, Safranow Krzysztof, Różański Jacek, Dębska-Ślizień Alicja, Domański Leszek, Dziewanowski Krzysztof, Głyda Maciej, Jankowska Magdalena, Noceń Małgorzata, Pabisiak Krzysztof, Rutkowski Bolesław, Wiśniewska Magda, Ciechanowski Kazimierz, Autosomal Dominant Polycystic Kidney Disease Is Not a Risk Factor for Post-transplant Diabetes Mellitus. Matched-pair Design Multicenter Study, 10.1016/j.arcmed.2007.10.003
  123. RUDERMAN IRENE, MASTERSON ROSEMARY, YATES CHRISTOPHER, GORELIK ALEXANDRA, COHNEY SHLOMO J, WALKER ROWAN G, New onset diabetes after kidney transplantation in autosomal dominant polycystic kidney disease: A retrospective cohort study : NODAT after kidney transplantation in ADPKD, 10.1111/j.1440-1797.2011.01507.x
  124. Sharp Cindy K., Zeligman Bernard E., Johnson Ann M., Duley Irene, Gabow Patricia A., Evaluation of colonic diverticular disease in autosomal dominant polycystic kidney disease without end-stage renal disease, 10.1016/s0272-6386(99)70043-0
  125. Lederman E. D., Am. Surg., 66, 200 (2000)
  126. Sarkio Susanna, Halme Leena, Kyllonen Lauri, Salmela Kaija, Severe gastrointestinal complications after 1,515 adult kidney transplantations, 10.1111/j.1432-2277.2004.tb00479.x
  127. Andreoni Kenneth A., Pelletier Ronald P., Elkhammas Elmahdi A., Davies Elizabeth A., Bumgardner Ginny L., Henry Mitchell L., Ferguson Ronald M., INCREASED INCIDENCE OF GASTROINTESTINAL SURGICAL COMPLICATIONS IN RENAL TRANSPLANT RECIPIENTS WITH POLYCYSTIC KIDNEY DISEASE1 : , 10.1097/00007890-199901270-00013
  128. Bretagnol A., Transpl. Int., 23, 878 (2010)
  129. Kasiske Bertram L., Snyder Jon J., Gilbertson David T., Wang Changchun, Cancer after Kidney Transplantation in the United States, 10.1111/j.1600-6143.2004.00450.x
  130. Otley Clark C., Cherikh Wida S., Salasche Stuart J., McBride Maureen A., Christenson Leslie J., Kauffman H. Myron, Skin cancer in organ transplant recipients: Effect of pretransplant end-organ disease, 10.1016/j.jaad.2005.07.061
  131. Shillingford J. M., Murcia N. S., Larson C. H., Low S. H., Hedgepeth R., Brown N., Flask C. A., Novick A. C., Goldfarb D. A., Kramer-Zucker A., Walz G., Piontek K. B., Germino G. G., Weimbs T., The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease, 10.1073/pnas.0509694103
  132. Qian Q., Du H., King B. F., Kumar S., Dean P. G., Cosio F. G., Torres V. E., Sirolimus Reduces Polycystic Liver Volume in ADPKD Patients, 10.1681/asn.2007050626
  133. Serra Andreas L., Poster Diane, Kistler Andreas D., Krauer Fabienne, Raina Shagun, Young James, Rentsch Katharina M., Spanaus Katharina S., Senn Oliver, Kristanto Paulus, Scheffel Hans, Weishaupt Dominik, Wüthrich Rudolf P., Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease, 10.1056/nejmoa0907419
  134. Walz Gerd, Budde Klemens, Mannaa Marwan, Nürnberger Jens, Wanner Christoph, Sommerer Claudia, Kunzendorf Ulrich, Banas Bernhard, Hörl Walter H., Obermüller Nicholas, Arns Wolfgang, Pavenstädt Hermann, Gaedeke Jens, Büchert Martin, May Christoph, Gschaidmeier Harald, Kramer Stefan, Eckardt Kai-Uwe, Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease, 10.1056/nejmoa1003491
  135. Canaud G., Am. J. Transplant., 10, 1701 (2010)
  136. Novalic Z., van der Wal A. M., Leonhard W. N., Koehl G., Breuning M. H., Geissler E. K., de Heer E., Peters D. J. M., Dose-Dependent Effects of Sirolimus on mTOR Signaling and Polycystic Kidney Disease, 10.1681/asn.2011040340
  137. Chrispijn Melissa, Gevers Tom J.G., Hol Jeroen C., Monshouwer Rene, Dekker Heleen M., Drenth Joost P.H., Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: Results from a randomized controlled trial, 10.1016/j.jhep.2013.03.004
  138. Torres V. E., Boletta A., Chapman A., Gattone V., Pei Y., Qian Q., Wallace D. P., Weimbs T., Wuthrich R. P., Prospects for mTOR Inhibitor Use in Patients with Polycystic Kidney Disease and Hamartomatous Diseases, 10.2215/cjn.01360210
  139. Spees E. K., Transplant. Proc., 22, 378 (1990)
  140. &NA;, THE POLYCYSTIC KIDNEY DONOR : , 10.1097/00007890-199212000-00042
  141. Canaud G., Knebelmann B., Harris P. C., Vrtovsnik F., Correas J.-M., Pallet N., Heyer C. M., Letavernier E., Bienaimé F., Thervet E., Martinez F., Terzi F., Legendre C., Therapeutic mTOR Inhibition in Autosomal Dominant Polycystic Kidney Disease: What Is the Appropriate Serum Level? : Low Dose of Rapamycin Fails to Prevent a Mild Form of PKD, 10.1111/j.1600-6143.2010.03152.x
  142. Howard Richard J., Reed Alan I., Van der Werf Willem J., Silkensen John A., Patton Pamela R., Scornik Juan C., DEVELOPMENT OF POLYCYSTIC DISEASE IN A KIDNEY 10 YEARS AFTER TRANSPLANTATION : , 10.1097/00007890-199911270-00034
  143. Koene R. A. P., Should polycystic kidneys ever be used for renal transplantation?, 10.1093/ndt/16.2.227